Sonida (SNDA) Q3 2026 Earnings Call Transcript

Sonida Senior Living reported Q3 adjusted EBITDA up 26.2% year over year to $46.8 million, normalized FFO of $0.46 per share, and same-store SHOP NOI growth of 15.6% to $52.0 million as occupancy rose 200 bps to 88.6%. The company expects to deploy $250 million in acquisition capital during 2026, excluding the CNL Healthcare Properties merger, and reported $98 million under contract; it also raised $68.6 million through ATM equity sales. Net leverage increased to 8.1x from 7.8x in Q2, while management targets 6x–6.5x and plans to provide full-year 2027 guidance with its Q4 results.

Analysis

The key question is whether operating gains can outrun the balance-sheet demands of growth. Sonida’s occupancy and labor execution create operating leverage, but as occupancy rises, incremental gains may become harder to capture; staffing quality, wage inflation and resident-acquisition costs will determine whether the reported flow-through persists. Its data-and-scale playbook could widen the gap versus smaller regional operators, while also making acquired assets and third-party management relationships more valuable. That advantage remains a management claim until sustained results demonstrate repeatable economics.

There is a capital-allocation tension: acquisitions and integration may lift NOI, but using revolving debt or issuing shares can dilute per-share value or slow deleveraging. Dispositions help only if proceeds are not recycled into lower-return assets. Also, the outsized recovery in the first transitioned CHP communities may reflect their unusually weak starting point, not a run rate for the remaining portfolio. Pro forma comparisons and non-GAAP measures warrant confirmation against filings and cash generation.

Near term, seasonality can distort sequential leverage; the more important test is whether leverage declines on a comparable basis. The 2027 guidance is the next meaningful catalyst, especially for organic NOI, integration savings and the path to management’s leverage target. Longer term, limited new supply may support pricing, but higher rates could raise acquisition financing costs and pressure valuations. A reversal in occupancy, labor-cost ratios, or per-share growth would undermine the thesis.

Key Decisions for Investors

• Treat SNDA as a conditional growth-and-deleveraging story, not a clean earnings beat. Avoid chasing ahead of 2027 guidance; consider a starter long only if guidance supports per-share growth alongside credible leverage reduction.
• Track comparable occupancy and NOI, labor cost as a share of revenue, free cash flow, and net leverage. Falsification signals: weakening occupancy or margins, leverage failing to trend down, or acquisition funding that relies on dilutive equity without clear per-share returns.
• Scrutinize the disposition-and-reinvestment cycle: require evidence that sale proceeds reduce debt or fund acquisitions with attractive, realized returns. The announced sale of low-fit assets does not by itself establish NAV or margin accretion.
• No distinct Ally Financial trade is indicated: its role in the article is as a lender, and the disclosed facility terms alone do not establish a material earnings catalyst for the lender.